Rispolept en es it fr

Category


add to favotites goo dig stu tec squ mys
fac del pro twi yah mya far


Rispolept Brand names, Rispolept Analogs

Rispolept Brand Names Mixture

  • No information avaliable

Rispolept Chemical_Formula

C23H27FN4O2

Rispolept RX_link

http://www.rxlist.com/cgi/generic/risperid.htm

Rispolept fda sheet

Rispolept FDA

Rispolept msds (material safety sheet)

Rispolept Synthesis Reference

L. E. J. Kennis, J. Vandenberk, U.S. Pat. 4,804,663 (1989)

Rispolept Molecular Weight

410.485 g/mol

Rispolept Melting Point

170oC

Rispolept H2O Solubility

2.8mg/L

Rispolept State

Solid

Rispolept LogP

2.718

Rispolept Dosage Forms

Tablet; Solution (oral)

Rispolept Indication

For the treatment of schizophrenia.

Rispolept Pharmacology

Risperidone is an atypical antipsychotic medication. It is most often used to treat delusional psychosis (including schizophrenia), but risperidone is also used to treat some forms of bipolar disorder and psychotic depression. It also has shown some success in treating symptoms of Asperger's Syndrome and autism. Risperidone is now the most commonly prescribed antipsychotic medication in the United States.

Rispolept Absorption

Well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.

Rispolept side effects and Toxicity

Symptoms of overdose include drowsiness, sedation, tachycardia, hypotension, and extrapyramidal symptoms. LD50=82.1mg/kg (orally in mice).

Rispolept Patient Information

PATIENT INFORMATION

Physicians are advised to discuss the following issues with patients for whom they prescribe RISPERDAL®:

Orthostatic Hypotension

Patients should be advised of the risk of orthostatic hypotension, especially during the period of initial
dose titration.

Interference With Cognitive and Motor Performance

Since RISPERDAL® has the potential toimpair judgment, thinking, or motor skills, patients should be cautioned
about operating hazardous machinery, including automobiles, until they are reasonably certain that RISPERDAL®
therapy does not affect them adversely.

Pregnancy

Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during
therapy.

Nursing

Patients should be advised not to breast-feed an infant if they are taking RISPERDAL.

Rispolept Organisms Affected

Humans and other mammals